help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on January 25, 2007, doi:10.1165/rcmb.2006-0410OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2006-0410OCv1
36/6/661    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, J.
Right arrow Articles by Mason, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, J.
Right arrow Articles by Mason, R. J.
American Journal of Respiratory Cell and Molecular Biology. Vol. 36, pp. 661-668, 2007
© 2007 American Thoracic Society
DOI: 10.1165/rcmb.2006-0410OC

Differentiated Human Alveolar Epithelial Cells and Reversibility of their Phenotype In Vitro

Jieru Wang, Karen Edeen, Rizwan Manzer, Yongsheng Chang, Shuanglin Wang, Xueni Chen, C.Joel Funk, Gregory P. Cosgrove, Xiaohui Fang and Robert J. Mason

Department of Medicine, National Jewish and Medical Research Center, Denver, Colorado; and Cardiovascular Research Institute, Department of Medicine, University of California San Francisco, San Francisco, California

Correspondence and requests for reprints should be addressed to Robert J. Mason, M.D., National Jewish and Medical Research Center, 1400 Jackson Street, Denver, CO 80206. E-mail: masonb{at}njc.org

Cultures of differentiating fetal human type II cells have been available for many years. However, studies with differentiated adult human type II cells are limited. We used a published method for type II cell isolation and developed primary culture systems for maintenance of differentiated adult human alveolar epithelial cells for in vitro studies. Human type II cells cultured on Matrigel (basolateral access) or a mixture of Matrigel and rat tail collagen (apical access) in the presence of keratinocyte growth factor, isobutylmethylxanthine, 8-bromo-cyclicAMP, and dexamethasone (KIAD) expressed the differentiated type II cell phenotype as measured by the expression of surfactant protein (SP)-A, SP-B, SP-C, and fatty acid synthase and their morphologic appearance. These cells contain lamellar inclusion bodies and have apical microvilli. In both systems the cells appear well differentiated. In the apical access system, type II cell differentiation markers initially decreased and then recovered over 6 d in culture. Lipid synthesis was also increased by the addition of KIAD. In contrast, type II cells cultured on rat tail collagen (or tissue culture plastic) slowly lose their lamellar inclusions and expression of the surfactant proteins and increase the expression of type I cell markers. The expression of the phenotypes is regulated by the culture conditions and is, in part, reversible in vitro.

Key Words: type I cell • type II cell • surfactant • lipogenesis


CLINICAL RELEVANCE

This report is important to our understanding of alveolar type II cell biology and defines critical differentiation factors required for the surfactant system in adult humans.

 






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2007 American Thoracic Society.
  ATS Best of the Web